AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day

BREAKING: Core CPI Steady, Jobless Claims Highest Since Oct. 2021 AbbVie (ABBV) stock definitively broke out Thursday after the pharma titan announced it had entered a settlement deal that will stave off generic Rinvoq until April 2037. But Rinvoq and Skyrizi revenue also stepped up markedly. Though they work differently from Humira, the duo treat a number of the same conditions. Last year, Rinvoq brought in $5.97 billion in sales, accounting for almost 11% of total sales. Skyrizi generated $11.72 billion. ...